午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook
Chinese English Germany Korean

ShangHai Biochempartner Co.,Ltd 企業(yè)の連絡先情報

名前:ShangHai Biochempartner Co.,Ltd
電話番號:177-54423994
電子メール:2853530910@QQ.com
國籍:China
ウェブサイト:www.biochempartner.com
商品の合計數(shù):7972
65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80

製品カタログ

Zunsemetinib1640282-42-3C25H22ClF2N5O3
BioE-11971268863-69-9C20H18FN3O2
Flotetuzumab1664355-28-5
OTX 008286936-40-1C52H72N8O8
1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione1380532-27-3C10H11F3N2O5
FTO-IN-32585198-87-2C12H10N4OS
YM150ダレキサバン365462-23-3C27H30N4O4
SBI-4251451272-71-1C13H12ClN3O4S
Ro60-0175Ro-60-0175169675-08-5C11H12ClFN2
2,4-Imidazolidinedione, 5-[3-[[4-[(3-methylphenyl)methoxy]phenyl]thio]-2-furanyl]-877176-23-3C21H18N2O4S
MRTX17192630904-45-7C23H18ClFN6O2
TH54272253744-56-6C20H20Cl2N8O3
Sigma-1 receptor antagonist 21639220-15-7C20H26ClN3O2
GSK2512125968-05-8C29H37FN6O4S
Erucinエルシン4430-36-8C6H11NS2
Ensitrelvir fumarate2757470-18-9C22H17ClF3N9O2.C4H4O4
Boc-Val-Ala-PAB-PNP1884578-00-0C27H34N4O9
1-Piperidinamine, N-hydroxy-N-nitroso-56329-24-9C5H11N3O2
Tamtuvetmab1608122-71-9
Blontuvetmab1608112-78-2
Tilavonemab2096513-89-0
Olendalizumab1337966-73-0
Garetosmabガレトスマブ（遺伝子組換え）2097125-54-5
Maftivimab2135632-36-7
Varisacumab1610010-60-0
Istiratumab1509928-04-4
Bermekimab1401965-15-8
Pepinemab2097151-87-4
Indusatumab1497400-26-6
Ravulizumabラブリズマブ（遺伝子組換え）1803171-55-2
Satralizumabサトラリズマブ（遺伝子組換え）1535963-91-7
Cabiralizumab1613144-80-1
Xentuzumab1417158-65-6
Enoblituzumab1353485-38-7
Refanezumab1233953-61-1
Mirvetuximab1453084-36-0
Tisotumab1418628-81-5
Brazikumab1610353-18-8
Emapalumabエマパルマブ（遺伝子組換え）1709815-23-5
Crizanlizumab1690318-25-2
Camrelizumab1798286-48-2
Ranevetmab1632282-27-9
Vunakizumab1792181-33-9
Depatuxizumab1471999-69-5
Lupartumab1640971-88-5
Utomilumab1417318-27-4
Telisotuzumab1781223-80-0
Aprutumab1634620-63-5
Elezanumab1791416-49-3
Lutikizumab1791411-57-8
Eptinezumabエプチネズマブ（遺伝子組換え）1644539-04-7
Fremanezumabフレマネズマブ（遺伝子組換え）1655501-53-3
Dezamizumab1662664-56-3
Suptavumab1629615-23-1
Birtamimab1608108-91-3
Setrusumab1847394-95-9
Rozanolixizumabロザノリキシズマブ（遺伝子組換え）1584645-37-3
Galcanezumabガルカネズマブ（遺伝子組換え）1578199-75-3
Erenumabエレヌマブ（遺伝子組換え）1582205-90-0
Carotuximab1268714-50-6
Timolumab1073538-99-4
Lanadelumabラナデルマブ（遺伝子組換え）1426055-14-2
Vonlerolizumab1638935-72-4
Duvortuxizumab1831098-91-9
Bleselumab1453067-91-8
Plozalizumab1610761-46-0
Trevogrumab1429201-24-0
Inebilizumabイネビリズマブ（遺伝子組換え）1299440-37-1
Navivumab1443004-16-7
Obiltoxaximab1351337-07-9
Tomaralimab1449294-76-1
Losatuxizumab1801544-27-3
Rovalpituzumab1613313-01-1
Ifabotuzumab1234137-51-9
Rinucumab1569263-06-4
Risankizumabリサンキズマブ（遺伝子組換え）1612838-76-2
Opicinumab1422268-07-2
Clivatuzumab Tetraxetan1462876-11-4
Ascrinvacumab1463459-96-2
Monalizumab1228763-95-8
Lilotomab1453362-55-4
Afasevikumab1589503-30-9
Vadastuximab1436390-63-4
Suvratoxumab1629620-18-3
Tomuzotuximab1646321-00-7
Zanidatamab
Gatipotuzumab1264737-26-9
Crotedumab1452387-69-7
Rivabazumab1627519-84-9
Navicixizumab1638338-43-8
Timigutuzumab1665274-14-5
Prezalumab1523164-68-2
Laprituximab1622327-38-1
Naratuximab1622327-39-2
Gilvetmab1808081-43-7
Letolizumab1450981-87-9
Porgaviximab1792982-55-8
Cosfroviximab1792982-57-0
Oleclumab1803176-05-7
Larcaviximab1792982-56-9
65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Copyright 2017 ? ChemicalBook. All rights reserved